6-152122626-C-T

Variant names:

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182961.4(SYNE1):c.26204G>A(p.Arg8735Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0361 in 1,614,050 control chromosomes in the GnomAD database, including 1,349 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.043 ( 148 hom., cov: 33)

Exomes 𝑓: 0.035 ( 1201 hom. )

Consequence

SYNE1
NM_182961.4 missense

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.0200

Variant links:

Genes affected

SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

SYNE1 links:

ESR1 (HGNC:3467): (estrogen receptor 1) This gene encodes an estrogen receptor and ligand-activated transcription factor. The canonical protein contains an N-terminal ligand-independent transactivation domain, a central DNA binding domain, a hinge domain, and a C-terminal ligand-dependent transactivation domain. The protein localizes to the nucleus where it may form either a homodimer or a heterodimer with estrogen receptor 2. The protein encoded by this gene regulates the transcription of many estrogen-inducible genes that play a role in growth, metabolism, sexual development, gestation, and other reproductive functions and is expressed in many non-reproductive tissues. The receptor encoded by this gene plays a key role in breast cancer, endometrial cancer, and osteoporosis. This gene is reported to have dozens of transcript variants due to the use of alternate promoters and alternative splicing, however, the full-length nature of many of these variants remain uncertain. [provided by RefSeq, Jul 2020]

ESR1 links:

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4

Computational evidence support a benign effect (MetaRNN=0.0023429394).

BP6

Variant 6-152122626-C-T is Benign according to our data. Variant chr6-152122626-C-T is described in ClinVar as [Benign]. Clinvar id is 130434.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152122626-C-T is described in Lovd as [Benign].

BA1

GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.063 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
SYNE1	NM_182961.4 link	c.26204G>A	p.Arg8735Gln	missense_variant	Exon 146 of 146	ENST00000367255.10	NP_892006.3
SYNE1	NM_001347702.2 link	c.2738G>A	p.Arg913Gln	missense_variant	Exon 18 of 18	ENST00000354674.5	NP_001334631.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
SYNE1	ENST00000367255.10 link	c.26204G>A	p.Arg8735Gln	missense_variant	Exon 146 of 146	1	NM_182961.4	ENSP00000356224.5		Q8NF91-1
SYNE1	ENST00000354674.5 link	c.2738G>A	p.Arg913Gln	missense_variant	Exon 18 of 18	5	NM_001347702.2	ENSP00000346701.4		F8WAI0

Frequencies

GnomAD3 genomes

AF:

0.0432

AC:

6568

AN:

152122

Hom.:

149

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0490

Gnomad AMI

AF:

0.00548

Gnomad AMR

AF:

0.0457

Gnomad ASJ

AF:

0.0490

Gnomad EAS

AF:

0.0630

Gnomad SAS

AF:

0.0686

Gnomad FIN

AF:

0.0629

Gnomad MID

AF:

0.0665

Gnomad NFE

AF:

0.0328

Gnomad OTH

AF:

0.0425

GnomAD3 exomes

AF:

0.0516

AC:

12978

AN:

251304

Hom.:

401

AF XY:

0.0498

AC XY:

6759

AN XY:

135824

show subpopulations

Gnomad AFR exome

AF:

0.0515

Gnomad AMR exome

AF:

0.0809

Gnomad ASJ exome

AF:

0.0447

Gnomad EAS exome

AF:

0.0574

Gnomad SAS exome

AF:

0.0651

Gnomad FIN exome

AF:

0.0720

Gnomad NFE exome

AF:

0.0351

Gnomad OTH exome

AF:

0.0492

GnomAD4 exome

AF:

0.0353

AC:

51632

AN:

1461810

Hom.:

1201

Cov.:

AF XY:

0.0360

AC XY:

26146

AN XY:

727200

show subpopulations

Gnomad4 AFR exome

AF:

0.0473

Gnomad4 AMR exome

AF:

0.0761

Gnomad4 ASJ exome

AF:

0.0455

Gnomad4 EAS exome

AF:

0.0549

Gnomad4 SAS exome

AF:

0.0620

Gnomad4 FIN exome

AF:

0.0719

Gnomad4 NFE exome

AF:

0.0281

Gnomad4 OTH exome

AF:

0.0415

GnomAD4 genome

AF:

0.0432

AC:

6570

AN:

152240

Hom.:

148

Cov.:

AF XY:

0.0456

AC XY:

3393

AN XY:

74420

show subpopulations

Gnomad4 AFR

AF:

0.0490

Gnomad4 AMR

AF:

0.0460

Gnomad4 ASJ

AF:

0.0490

Gnomad4 EAS

AF:

0.0626

Gnomad4 SAS

AF:

0.0691

Gnomad4 FIN

AF:

0.0629

Gnomad4 NFE

AF:

0.0328

Gnomad4 OTH

AF:

0.0412

Alfa

AF:

0.0336

Hom.:

189

Bravo

AF:

0.0419

TwinsUK

AF:

0.0245

AC:

ALSPAC

AF:

0.0231

AC:

ESP6500AA

AF:

0.0406

AC:

179

ESP6500EA

AF:

0.0335

AC:

288

ExAC

AF:

0.0509

AC:

6175

Asia WGS

AF:

0.0720

AC:

251

AN:

3478

EpiCase

AF:

0.0305

EpiControl

AF:

0.0306

ClinVar

Significance: Benign

Submissions summary: Benign:8

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not specified

Benign:5

PreventionGenetics, part of Exact Sciences

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Feb 26, 2016

GeneDx

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center

Significance: Benign

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

Genetic Services Laboratory, University of Chicago

Significance: Likely benign

Review Status: no assertion criteria provided

Collection Method: clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Clinical Genetics, Academic Medical Center

Significance: Benign

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant

Benign:1

Feb 03, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Autosomal recessive ataxia, Beauce type

Benign:1

Jan 13, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Emery-Dreifuss muscular dystrophy 4, autosomal dominant

Benign:1

Jan 13, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Benign

0.072

BayesDel_addAF

Benign

-0.60

BayesDel_noAF

Benign

-0.57

CADD

Benign

8.4

DANN

Benign

0.90

DEOGEN2

Benign

0.17

T;.;.;T;T

Eigen

Benign

-0.95

Eigen_PC

Benign

-0.91

FATHMM_MKL

Benign

0.077

LIST_S2

Benign

0.75

T;T;T;T;T

MetaRNN

Benign

0.0023

T;T;T;T;T

MetaSVM

Benign

-1.0

MutationAssessor

Benign

-0.14

N;.;.;.;.

PrimateAI

Benign

0.22

PROVEAN

Benign

-1.6

N;D;N;N;N

REVEL

Benign

0.022

Sift

Benign

0.22

T;D;T;T;T

Sift4G

Benign

0.48

T;T;T;T;T

Polyphen

0.0040

B;.;.;.;.

Vest4

0.043

MPC

0.15

ClinPred

0.0024

GERP RS

1.3

Varity_R

0.060

gMVP

0.28

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

LitVar

Other links and lift over